[Laser irradiation in the treatment of ischemic heart disease]

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Physics

Background:

• Ischemic heart disease (IHD) poses significant risks for cardiac remodeling and failure.
• Beta-blockers like carvedilol are standard treatments for IHD.
• Exploring novel therapeutic modalities is crucial for improving patient outcomes.

Purpose of the Study:

• To compare the cardiodynamic effects of carvedilol and low-intensity infrared laser radiation in IHD patients.
• To evaluate the potential of laser therapy as a neurohormonal modulator.
• To assess the feasibility of laser use in reducing cardiac remodeling and preventing heart failure.

Main Methods:

• A comparative study involving 115 patients diagnosed with ischemic heart disease.
• Administration of beta-blocker carvedilol.
• Exposure to low-intensity infrared laser radiation.
• Assessment of cardiodynamic parameters, including heart contractility and diastolic function.

Main Results:

• Both carvedilol and infrared laser radiation demonstrated comparable positive effects on cardiac contractility.
• Similar improvements were observed in diastolic function for both treatment groups.
• The findings support the similar efficacy of both interventions on key cardiac parameters.

Conclusions:

• Low-intensity infrared laser radiation shows comparable cardiodynamic benefits to carvedilol in IHD patients.
• Laser therapy presents a feasible option as a neurohormonal modulator.
• This approach may offer a novel strategy for reducing cardiac remodeling and preventing heart failure in IHD.